Zenas BioPharma, Inc. (ZBIO) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Zenas BioPharma, Inc. (ZBIO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $889.7M, listed on NASDAQ, employing roughly 130 people, carrying a beta of -0.58 to the broader market. Zenas BioPharma, Inc. Led by Leon Oliver Moulder Jr., public since 2024-09-13.
Snapshot as of May 15, 2026.
- Spot Price
- $18.31
- Total OI
- 4.9K